Cellix Bio Pharma, a global contract research organization (CRO), transforms today’s healthcare challenges into tomorrow’s solutions. Cellix Bio Pharma is an experienced CRO focused on development of pharmaceutical formulations. Cellix Bio Pharma focuses to combine the AI computational power to the chemical and biological space in order to streamline drug discovery, design, development, and optimization that can expedite drug development.
Hyderabad, India, April 10, 2020 –(PR.com)– Cellix Bio Pharma initiates the acquisition of Avaca Pharma, a formulation development CRO. Avaca Pharma services include discovery, formulation development, regulatory support, and product development activities.
The acquisition of Avaca Pharma provides Cellix Bio Pharma with world-class expertise in NME/NCE discovery R&D services and a unique and extensive set of high-content and complex formulations. Combined with Cellix Bio’s established small molecule discovery and development capabilities, this expansion uniquely position Cellix Bio Pharma as a leading provider of integrated R&D services across both large and small molecule platforms and provides a base for further expansion.
With a shared vision of an innovative approach to execution, exceptional customer service, and focus on providing value, Cellix Bio Pharma is delighted to offer expanded leading-edge service solutions to their clients.
Let’s block ads! (Why?)
Key takeaways:Sumit Nagal is India's top-ranked men's singles tennis player, competing regularly across the ATP…
Key takeaways:Official live streaming options and broadcast channels for Al-Faisaly vs Al-Nassr are available through…
Key takeaways:Day one of the 2026 US Grand Prix was reported, but no specific Bottas…
Key takeaways:India Women completed an emphatic series sweep against Zimbabwe Women in the 2026 3rd…
Key takeaways:Lok Sabha Speaker Om Birla said any fresh motion or notice to remove CEC…
Key takeaways:Ekaterina Alexandrova is a top-ranking Russian professional tennis player known for her powerful flat…